FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced that the US Food and Drug Administration (FDA) has accepted its ...
Monthly Prescribing Reference22h
FDA to Review Sublingual Cyclobenzaprine for Fibromyalgia Management
The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.
The Globe and Mail21h
This Micro Cap Is Getting Bid Up Prior To Opening Bell
A New Jersey-based biotech company is finding quite a bit of success so far during Tuesday’s premarket hours after the ...
Stocktwits on MSN3h
Tonix Pharma Stock’s Retail Chatter Explodes After FDA Nod For New Drug Application
Tonix Pharmaceuticals was the most active symbol on Stocktwits before the bell on Wednesday as shares of the clinical-stage ...